Aduhelm (Drug)

Social Security’s Cost-of-Living Increase Will Be Largest in Four Decades, an Estimate Says

More than 70 million Americans who receive Social Security benefits can expect an inflation adjustment to their monthly checks next year that will be the largest in four decades. Government inflation figures for August, released on Tuesday, point to a Social Security cost-of-living adjustment, known as the COLA, of 8.7 percent, according to an estimate […]

Know More

Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug

In the interview, Mr. Johns echoed these explanations. Asked if association officials had communicated with Biogen since Medicare’s proposal, he said, “I think probably some of our folks have had a conversation or more along the way” and that Biogen’s staff “occasionally pass along a piece of information, but I can tell you that we […]

Know More

Senate Confirms Califf as F.D.A. Chief in Tight Vote

The Senate on Tuesday narrowly confirmed Dr. Robert Califf as commissioner of the Food and Drug Administration, a key federal agency that has been without a permanent chief for more than a yearlong stretch of the coronavirus pandemic. The vote was 50-46, with six Republicans crossing the aisle to support him while five Democrats opposed […]

Know More

Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decision

Posts supporting coverage include comments from people who have consulted for Biogen, like Dr. Jeffrey Cummings, a research professor in the department of brain health at the University of Nevada Las Vegas. He wrote that the drug “prolongs the mental life of our declining patients,” adding, “Medicare should unequivocally support coverage for aducanumab, and they […]

Know More

Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug

Safety data from those trials was published Monday in the journal JAMA Neurology in a study whose authors included eight Biogen employees. The data showed that 425 of 1,029 patients, or 41 percent, who received the high dose of the drug — the dose that the F.D.A. later approved — experienced either brain swelling or […]

Know More